BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15280777)

  • 21. Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania--a prospective cost-effectiveness study.
    Robberstad B; Evjen-Olsen B
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):397-403. PubMed ID: 20739897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.
    Karnon J; Orji N
    Health Policy Plan; 2016 Oct; 31(8):1133-41. PubMed ID: 27016949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-cost drug cuts perinatal HIV-transmission rate.
    McCarthy M
    Lancet; 1999 Jul; 354(9175):309. PubMed ID: 10440319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
    Skordis J; Nattrass N
    J Health Econ; 2002 May; 21(3):405-21. PubMed ID: 12022266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.
    Ciaranello AL; Perez F; Engelsmann B; Walensky RP; Mushavi A; Rusibamayila A; Keatinge J; Park JE; Maruva M; Cerda R; Wood R; Dabis F; Freedberg KA
    Clin Infect Dis; 2013 Feb; 56(3):430-46. PubMed ID: 23204035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.
    Becquet R; Bequet L; Ekouevi DK; Viho I; Sakarovitch C; Fassinou P; Bedikou G; Timite-Konan M; Dabis F; Leroy V;
    PLoS Med; 2007 Jan; 4(1):e17. PubMed ID: 17227132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.
    Meisner J; Roberts DA; Rodriguez P; Sharma M; Newman Owiredu M; Gomez B; de Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Farid S; Essajee S; Jamil MS; Baggaley R; Johnson C; Drake AL
    J Int AIDS Soc; 2021 Apr; 24(4):e25686. PubMed ID: 33787064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia.
    Stringer EM; Sinkala M; Stringer JS; Mzyece E; Makuka I; Goldenberg RL; Kwape P; Chilufya M; Vermund SH
    AIDS; 2003 Jun; 17(9):1377-82. PubMed ID: 12799559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.
    Boeke CE; Jackson JB
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(3):133-40. PubMed ID: 18460695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
    Gopalappa C; Stover J; Shaffer N; Mahy M
    AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa.
    Stringer JS; Rouse DJ; Vermund SH; Goldenberg RL; Sinkala M; Stinnett AA
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):369-77. PubMed ID: 11015154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.
    Ishikawa N; Shimbo T; Miyano S; Sikazwe I; Mwango A; Ghidinelli MN; Syakantu G
    PLoS One; 2014; 9(3):e90991. PubMed ID: 24604067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.
    Bautista-Arredondo S; Sosa-Rubí SG; Opuni M; Contreras-Loya D; Kwan A; Chaumont C; Chompolola A; Condo J; Galárraga O; Martinson N; Masiye F; Nsanzimana S; Ochoa-Moreno I; Wamai R; Wang'ombe J;
    AIDS; 2016 Oct; 30(16):2495-2504. PubMed ID: 27753679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda.
    Napyo A; Tylleskär T; Mukunya D; Tumuhamye J; Musaba MW; Ojok Arach AA; Waako P; Tumwine JK; Ndeezi G
    PLoS One; 2020; 15(10):e0240529. PubMed ID: 33057393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs and economies of scale in the accelerated program for prevention of mother-to-child transmission of HIV in Zimbabwe.
    Ochoa-Moreno I; Bautista-Arredondo S; McCoy SI; Buzdugan R; Mangenah C; Padian NS; Cowan FM
    PLoS One; 2020; 15(5):e0231527. PubMed ID: 32433715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India.
    Dandona L; Kumar SG; Ramesh YK; Rao MC; Marseille E; Kahn JG; Dandona R
    BMC Health Serv Res; 2008 Jan; 8():26. PubMed ID: 18234117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.